CULLINAN THERAPEUTICS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-29.8M | $-29.8M | $10.0K | $14.9M |
| FY2021 | $-43.4M | $-43.4M | $0 | $24.4M |
| FY2022 | $-126.7M | $-127.8M | $1.1M | $28.0M |
| FY2023 | $-134.3M | $-134.5M | $208.0K | $30.4M |
| FY2024 | $-145.3M | $-145.3M | $0 | $37.8M |
| FY2025 | $-175.8M | $-175.8M | $49.0K | $36.0M |